Metoklopramid (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metoklopramid" in Turkish language version.

refsWebsite

Global rank Turkish rank

42web.archive.org

1^st place

17nih.gov

4^th place

11^th place

13doi.org

2^nd place

4^th place

6books.google.com

3^rd place

5^th place

4drugs.com

399^th place

156^th place

4fda.gov

447^th place

858^th place

2europa.eu

68^th place

79^th place

2nytimes.com

7^th place

36^th place

1medlineplus.gov

1,581^st place

1,676^th place

1tga.gov.au

3,984^th place

3,256^th place

1pharmacytimes.com

low place

1handle.net

102^nd place

447^th place

1clincalc.com

3,912^th place

2,106^th place

1mydr.com.au

low place

1medicines.org.uk

3,823^rd place

3,999^th place

1ambulance.vic.gov.au

low place

1archive.org

6^th place

1webmd.com

1,169^th place

378^th place

1aspetjournals.org

6,663^rd place

low place

1persee.fr

515^th place

1,440^th place

1lesechos.fr

605^th place

9,988^th place

1bnf.fr

124^th place

980^th place

1pmlive.com

low place

1vahistorical.org

low place

1pharmamedtechbi.com

low place

1epmonthly.com

low place

1bc.edu

4,784^th place

8,320^th place

1law360.com

6,282^nd place

low place

1jstor.org

26^th place

90^th place

1americanbar.org

7,096^th place

low place

1pepperlaw.com

low place

1findlaw.com

1,478^th place

6,665^th place

1scotusblog.com

7,147^th place

low place

1today.com

396^th place

1,677^th place

1statnews.com

8,771^st place

low place

1raps.org

low place

1elephantcare.org

low place

ambulance.vic.gov.au

"Ambulance Victoria Clinical Guideline A0701""Oxygen Therapy" (PDF). Ambulance Victoria. 2013. 12 March 2015 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 December 2014.

americanbar.org

Noah L (Spring–Summer 2010). "Adding Insult to Injury: Paying For Harms Caused by a Competitor's Copycat Product" (PDF). Tort Trial & Insurance Practice Law Journal. 45 (3–4): 673–695. JSTOR 41059447. 11 October 2016 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 25 August 2016.

archive.org

Briggs GG, Freeman RK, Yaffe SJ (2008). Drugs in Pregnancy and Lactation (8th bas.). Philadelphia: Lippincott Williams & Wilkins. ss. 1197–1200. ISBN 978-0-7817-7876-3. Erişim tarihi: 11 June 2009.

aspetjournals.org

jpet.aspetjournals.org

Matsui A, Matsuo H, Takanaga H, Sasaki S, Maeda M, Sawada Y (November 1998). "Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain". The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 725–732. PMID 9808703. 28 August 2021 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 21 January 2018.

bc.edu

lawdigitalcommons.bc.edu

Stoddart A (2012). "Missing After Mensing: A Remedy for Generic Drug Consumers". Boston College Law Review. 53: 1967–2001. 14 December 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.

bnf.fr

data.bnf.fr

"Laboratoires Delagrange (1932) - Organisation - Resources from the BnF". Data.bnf.fr. 21 November 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.

books.google.com

Dobbs MR (2009). Clinical Neurotoxicology E-Book: Syndromes, Substances, Environments. Elsevier Health Sciences. s. 393. ISBN 978-0-323-07099-7. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 March 2023.
Fischer J, Gere A (2006). "Timing of Analog Research in Medicinal Chemistry. Chapter 6". Chorghade MS (Ed.). Drug Discovery and Development. 1. John Wiley & Sons. ss. 203–205. ISBN 978-0-471-78009-0. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
Sneader W (31 October 2005). Drug Discovery: A History. John Wiley & Sons. ss. 205–. ISBN 978-0-470-01552-0. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
Landry Y (2011). Petite histoire des médicaments: De l'Antiquité à nos jours. Dunod. s. 182. ISBN 978-2-10-057130-7. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
"Metoclopramide hydrochloride". Pharmaceutical Manufacturing Encyclopedia. 1–4 (3rd bas.). Elsevier. 2013. ss. 179m. ISBN 978-0-8155-1856-3. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
Hamilton RJ (2010). Tarascon Pharmacopoeia 2010 Library Edition. Jones & Bartlett Learning. s. 170. ISBN 978-0-7637-7768-5. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 September 2017.

clincalc.com

"Metoclopramide - Drug Usage Statistics". ClinCalc. 13 November 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 October 2022.

doi.org

Becker WJ (June 2015). "Acute Migraine Treatment in Adults". Headache. 55 (6): 778–793. doi:10.1111/head.12550. PMID 25877672.
Derry S, Moore RA (April 2013). "Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults". The Cochrane Database of Systematic Reviews. 2013 (4): CD008040. doi:10.1002/14651858.CD008040.pub3. PMC 4161111 $2. PMID 23633349.
Rao AS, Camilleri M (January 2010). "Review article: metoclopramide and tardive dyskinesia". Alimentary Pharmacology & Therapeutics. 31 (1): 11–19. doi:10.1111/j.1365-2036.2009.04189.x. PMID 19886950.
Forinash AB, Yancey AM, Barnes KN, Myles TD (October 2012). "The use of galactogogues in the breastfeeding mother". The Annals of Pharmacotherapy. 46 (10): 1392–1404. doi:10.1345/aph.1R167. PMID 23012383.
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A (June 2009). "The safety of metoclopramide use in the first trimester of pregnancy". The New England Journal of Medicine. 360 (24): 2528–2535. doi:10.1056/NEJMoa0807154. PMID 19516033.
Pasternak B, Svanström H, Mølgaard-Nielsen D, Melbye M, Hviid A (October 2013). "Metoclopramide in pregnancy and risk of major congenital malformations and fetal death". JAMA. 310 (15): 1601–1611. doi:10.1001/jama.2013.278343. PMID 24129464.
Hibbs AM, Lorch SA (August 2006). "Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review". Pediatrics. 118 (2): 746–752. doi:10.1542/peds.2005-2664. PMID 16882832.
Surawski RJ, Quinn DK (2011). "Metoclopramide and homicidal ideation: a case report and literature review". Psychosomatics. 52 (5): 403–409. doi:10.1016/j.psym.2011.02.001. PMID 21907057.
Tonini M, Candura SM, Messori E, Rizzi CA (May 1995). "Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis". Pharmacological Research. 31 (5): 257–260. doi:10.1016/1043-6618(95)80029-8. PMID 7479521.
Livezey MR, Briggs ED, Bolles AK, Nagy LD, Fujiwara R, Furge LL (April 2014). "Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 44 (4): 309–319. doi:10.3109/00498254.2013.835885. PMC 4059401 $2. PMID 24010633.
Sanger GJ (December 2009). "Translating 5-HT receptor pharmacology". Neurogastroenterology and Motility. 21 (12): 1235–1238. doi:10.1111/j.1365-2982.2009.01425.x. PMID 19906028.
Henzi I, Tramèr MR (2003). "Metoclopramide for the Control of Postoperative Nausea and Vomiting". Donnerer J (Ed.). Antiemetic Therapy. ss. 161–168. doi:10.1159/000071415. ISBN 3-8055-7547-5.
Wiholm BE, Mortimer O, Boethius G, Häggström JE (February 1984). "Tardive dyskinesia associated with metoclopramide". British Medical Journal. 288 (6416): 545–547. doi:10.1136/bmj.288.6416.545. PMC 1444584 $2. PMID 6421373.

drugs.com

"International names for metoclopramide". Drugs.com. 13 February 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 March 2016.
"Metoclopramide Use During Pregnancy". Drugs.com. 27 February 2020. 21 March 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.
"Metoclopramide hydrochloride". Monograph. The American Society of Health-System Pharmacists. 19 August 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 September 2014.
"Anagraine - Drugs.com". Drugs.com. 29 August 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 May 2020.

elephantcare.org

Mikota SK, Plumb DC (June 2003). "Metoclopramide HCl". The Elephant Formulary. Elephant Care International. 29 December 2003 tarihinde kaynağından arşivlendi.

epmonthly.com

"All About Metoclopramide (Reglan)". Emergency Physicians Monthly. EPMonthly.com. 15 August 2014. 21 January 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.

europa.eu

ema.europa.eu

"Metoclopramide-containing medicines". European Medicines Agency. 17 September 2018. 20 June 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
"Metoclopramide only containing medicinal products" (PDF). EMA/753989/2013 Assessment report. European Medicines Agency. 20 December 2013. 26 August 2016 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 25 August 2016.

fda.gov

accessdata.fda.gov

"New Drug Application (NDA): 017862 - Approval history - Hikma Metoclopramide Hydrochloride". U.S. Food and Drug Administration. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 March 2022.
"New Drug Application (NDA): 017854: Approval history - Ani Pharms Metoclopramide Hydrochloride". U.S. Food and Drug Administration. 8 March 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 March 2022.
"TEVA Metoclopramide Hydrochloride". Abbreviated New Drug Application (ANDA): 070184. U.S. Food and Drug Administration. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 March 2022.

fda.gov

"FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs" (Basın açıklaması). U.S. Food and Drug Administration. 26 February 2009. 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009. "Lay Summary – WebMD". 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009.

findlaw.com

caselaw.findlaw.com

"CONTE v. WYETH INC (2008)". Erişim tarihi: 25 Temmuz 2024.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

jstor.org

Noah L (Spring–Summer 2010). "Adding Insult to Injury: Paying For Harms Caused by a Competitor's Copycat Product" (PDF). Tort Trial & Insurance Practice Law Journal. 45 (3–4): 673–695. JSTOR 41059447. 11 October 2016 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 25 August 2016.

law360.com

Casey S (24 October 2012). "Generic Pharmaceutical Liability: Challenges And Changes". Law360. 28 April 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016. com

lesechos.fr

Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Lesechos.fr. Les Echos. 16 October 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.

medicines.org.uk

xpil.medicines.org.uk

"Metoclopramide Hydrochloride 5mg/5ml Oral Solution - - (eMC)". xpil.medicines.org.uk. 3 March 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 July 2013.

medlineplus.gov

"Metoclopramide". MedlinePlus. 5 October 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.

mydr.com.au

"Maxolon (Australian Approved Product Information)". Valeant Pharmaceuticals. 2000. 7 November 2011 tarihinde kaynağından arşivlendi.

nih.gov

ncbi.nlm.nih.gov

Becker WJ (June 2015). "Acute Migraine Treatment in Adults". Headache. 55 (6): 778–793. doi:10.1111/head.12550. PMID 25877672.
Derry S, Moore RA (April 2013). "Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults". The Cochrane Database of Systematic Reviews. 2013 (4): CD008040. doi:10.1002/14651858.CD008040.pub3. PMC 4161111 $2. PMID 23633349.
Rao AS, Camilleri M (January 2010). "Review article: metoclopramide and tardive dyskinesia". Alimentary Pharmacology & Therapeutics. 31 (1): 11–19. doi:10.1111/j.1365-2036.2009.04189.x. PMID 19886950.
Bazzano AN, Hofer R, Thibeau S, Gillispie V, Jacobs M, Theall KP (2016). "A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding". The Ochsner Journal. 16 (4): 511–524. PMC 5158159 $2. PMID 27999511.
Forinash AB, Yancey AM, Barnes KN, Myles TD (October 2012). "The use of galactogogues in the breastfeeding mother". The Annals of Pharmacotherapy. 46 (10): 1392–1404. doi:10.1345/aph.1R167. PMID 23012383.
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A (June 2009). "The safety of metoclopramide use in the first trimester of pregnancy". The New England Journal of Medicine. 360 (24): 2528–2535. doi:10.1056/NEJMoa0807154. PMID 19516033.
Pasternak B, Svanström H, Mølgaard-Nielsen D, Melbye M, Hviid A (October 2013). "Metoclopramide in pregnancy and risk of major congenital malformations and fetal death". JAMA. 310 (15): 1601–1611. doi:10.1001/jama.2013.278343. PMID 24129464.
Hibbs AM, Lorch SA (August 2006). "Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review". Pediatrics. 118 (2): 746–752. doi:10.1542/peds.2005-2664. PMID 16882832.
Surawski RJ, Quinn DK (2011). "Metoclopramide and homicidal ideation: a case report and literature review". Psychosomatics. 52 (5): 403–409. doi:10.1016/j.psym.2011.02.001. PMID 21907057.
Isola S, Adams N (2020). "Metoclopramide". Statpearls. PMID 30137802.
Matsui A, Matsuo H, Takanaga H, Sasaki S, Maeda M, Sawada Y (November 1998). "Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain". The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 725–732. PMID 9808703. 28 August 2021 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 21 January 2018.
Tonini M, Candura SM, Messori E, Rizzi CA (May 1995). "Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis". Pharmacological Research. 31 (5): 257–260. doi:10.1016/1043-6618(95)80029-8. PMID 7479521.
Livezey MR, Briggs ED, Bolles AK, Nagy LD, Fujiwara R, Furge LL (April 2014). "Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 44 (4): 309–319. doi:10.3109/00498254.2013.835885. PMC 4059401 $2. PMID 24010633.
Sanger GJ (December 2009). "Translating 5-HT receptor pharmacology". Neurogastroenterology and Motility. 21 (12): 1235–1238. doi:10.1111/j.1365-2982.2009.01425.x. PMID 19906028.
Justin-Besancon L, Laville C (1964). "[Antiemetic Action of Metoclopramide with Respect to Apomorphine and Hydergine]". Comptes Rendus des Séances de la Société de Biologie et de ses Filiales (Fransızca). 158: 723–727. PMID 14186927.
Wiholm BE, Mortimer O, Boethius G, Häggström JE (February 1984). "Tardive dyskinesia associated with metoclopramide". British Medical Journal. 288 (6416): 545–547. doi:10.1136/bmj.288.6416.545. PMC 1444584 $2. PMID 6421373.

dailymed.nlm.nih.gov

"Reglan- metoclopramide hydrochloride tablet". DailyMed. 19 June 2020. 30 November 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.

nytimes.com

Petersen M (11 March 2002). "American Home Is Changing Name to Wyeth". The New York Times. 10 May 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 February 2017.
Liptak A (23 June 2011). "Drug Makers Win Two Supreme Court Decisions". The New York Times. 27 April 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 February 2017.

pepperlaw.com

Rothschild E (16 March 2016). "Calif. Asks Innovator Drug Brands To Do The Impossible". Pepper Hamilton LLP's Insight Center. 5 August 2016 tarihinde kaynağından arşivlendi.

persee.fr

Lefebvre T, Raynal C (2007). "La mystérieuse bonbonne des Laboratoires Delagrange [Q265, Usage des bonbonnes]". Revue d'Histoire de la Pharmacie. 94 (353): 160–162. 10 May 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.

pharmacytimes.com

Bartholow M. "Top 200 Drugs of 2012". Pharmacy Times. 17 May 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 April 2014.

pharmamedtechbi.com

pink.pharmamedtechbi.com

Staff (29 September 1986). "FDA's Oral Verapamil ANDA Approvals on Eve of Exclusivity Expiration Pit Five Generic Products V. Calan, Isoptin; Inderal, Reglan Indications No Longer Exclusive". The Pink Sheet. 10 May 2017 tarihinde kaynağından arşivlendi.

pmlive.com

Meek T (24 May 2013). "A look back at Sanofi's merger with Synthélabo". PMLiVE. Pmlive.com. 26 August 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.

raps.org

Brennan Z (8 July 2016). "Generic Drug Labels: FDA Offers Draft Guidance on Updates After Reference Products are Withdrawn". Regulatory Focus. 11 August 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.

scotusblog.com

"PLIVA, Inc. v. Mensing". SCOTUSblog (İngilizce). Erişim tarihi: 2024-07-25.

statnews.com

Silverman E (19 May 2016). "FDA delays rule to allow generic drug makers to change labels". Pharmalot. Statnews.com. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.

tga.gov.au

"Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. 8 April 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 April 2014.

today.com

Rossen J, Patel A (8 November 2013). "FDA moves to make generic drugmakers more accountable". Today.com. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.

vahistorical.org

"Virginia Historical Society A Guide to the A. H. Robins Company Records, 1885–2004." Vahistorical.org. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.

web.archive.org

"International names for metoclopramide". Drugs.com. 13 February 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 March 2016.
"Metoclopramide Use During Pregnancy". Drugs.com. 27 February 2020. 21 March 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.
"Reglan- metoclopramide hydrochloride tablet". DailyMed. 19 June 2020. 30 November 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.
"Metoclopramide". MedlinePlus. 5 October 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 November 2020.
"Metoclopramide hydrochloride". Monograph. The American Society of Health-System Pharmacists. 19 August 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 September 2014.
"Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. 8 April 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 April 2014.
Bartholow M. "Top 200 Drugs of 2012". Pharmacy Times. 17 May 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 April 2014.
"Metoclopramide - Drug Usage Statistics". ClinCalc. 13 November 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 October 2022.
"Maxolon (Australian Approved Product Information)". Valeant Pharmaceuticals. 2000. 7 November 2011 tarihinde kaynağından arşivlendi.
"Metoclopramide Hydrochloride 5mg/5ml Oral Solution - - (eMC)". xpil.medicines.org.uk. 3 March 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 July 2013.
"Ambulance Victoria Clinical Guideline A0701""Oxygen Therapy" (PDF). Ambulance Victoria. 2013. 12 March 2015 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 December 2014.
"Metoclopramide-containing medicines". European Medicines Agency. 17 September 2018. 20 June 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
"Metoclopramide only containing medicinal products" (PDF). EMA/753989/2013 Assessment report. European Medicines Agency. 20 December 2013. 26 August 2016 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 25 August 2016.
"FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs" (Basın açıklaması). U.S. Food and Drug Administration. 26 February 2009. 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009. "Lay Summary – WebMD". 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009.
Dobbs MR (2009). Clinical Neurotoxicology E-Book: Syndromes, Substances, Environments. Elsevier Health Sciences. s. 393. ISBN 978-0-323-07099-7. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 March 2023.
Matsui A, Matsuo H, Takanaga H, Sasaki S, Maeda M, Sawada Y (November 1998). "Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain". The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 725–732. PMID 9808703. 28 August 2021 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 21 January 2018.
Fischer J, Gere A (2006). "Timing of Analog Research in Medicinal Chemistry. Chapter 6". Chorghade MS (Ed.). Drug Discovery and Development. 1. John Wiley & Sons. ss. 203–205. ISBN 978-0-471-78009-0. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
Sneader W (31 October 2005). Drug Discovery: A History. John Wiley & Sons. ss. 205–. ISBN 978-0-470-01552-0. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
Landry Y (2011). Petite histoire des médicaments: De l'Antiquité à nos jours. Dunod. s. 182. ISBN 978-2-10-057130-7. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
Lefebvre T, Raynal C (2007). "La mystérieuse bonbonne des Laboratoires Delagrange [Q265, Usage des bonbonnes]". Revue d'Histoire de la Pharmacie. 94 (353): 160–162. 10 May 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Lesechos.fr. Les Echos. 16 October 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
"Laboratoires Delagrange (1932) - Organisation - Resources from the BnF". Data.bnf.fr. 21 November 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.
Meek T (24 May 2013). "A look back at Sanofi's merger with Synthélabo". PMLiVE. Pmlive.com. 26 August 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
"Metoclopramide hydrochloride". Pharmaceutical Manufacturing Encyclopedia. 1–4 (3rd bas.). Elsevier. 2013. ss. 179m. ISBN 978-0-8155-1856-3. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 August 2016.
"New Drug Application (NDA): 017862 - Approval history - Hikma Metoclopramide Hydrochloride". U.S. Food and Drug Administration. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 March 2022.
"New Drug Application (NDA): 017854: Approval history - Ani Pharms Metoclopramide Hydrochloride". U.S. Food and Drug Administration. 8 March 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 March 2022.
"Virginia Historical Society A Guide to the A. H. Robins Company Records, 1885–2004." Vahistorical.org. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.
Petersen M (11 March 2002). "American Home Is Changing Name to Wyeth". The New York Times. 10 May 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 February 2017.
Staff (29 September 1986). "FDA's Oral Verapamil ANDA Approvals on Eve of Exclusivity Expiration Pit Five Generic Products V. Calan, Isoptin; Inderal, Reglan Indications No Longer Exclusive". The Pink Sheet. 10 May 2017 tarihinde kaynağından arşivlendi.
"All About Metoclopramide (Reglan)". Emergency Physicians Monthly. EPMonthly.com. 15 August 2014. 21 January 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.
"TEVA Metoclopramide Hydrochloride". Abbreviated New Drug Application (ANDA): 070184. U.S. Food and Drug Administration. 25 July 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 March 2022.
Stoddart A (2012). "Missing After Mensing: A Remedy for Generic Drug Consumers". Boston College Law Review. 53: 1967–2001. 14 December 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
Casey S (24 October 2012). "Generic Pharmaceutical Liability: Challenges And Changes". Law360. 28 April 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016. com
Noah L (Spring–Summer 2010). "Adding Insult to Injury: Paying For Harms Caused by a Competitor's Copycat Product" (PDF). Tort Trial & Insurance Practice Law Journal. 45 (3–4): 673–695. JSTOR 41059447. 11 October 2016 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 25 August 2016.
Rothschild E (16 March 2016). "Calif. Asks Innovator Drug Brands To Do The Impossible". Pepper Hamilton LLP's Insight Center. 5 August 2016 tarihinde kaynağından arşivlendi.
Liptak A (23 June 2011). "Drug Makers Win Two Supreme Court Decisions". The New York Times. 27 April 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 February 2017.
Rossen J, Patel A (8 November 2013). "FDA moves to make generic drugmakers more accountable". Today.com. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.
Silverman E (19 May 2016). "FDA delays rule to allow generic drug makers to change labels". Pharmalot. Statnews.com. 1 December 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 January 2018.
Brennan Z (8 July 2016). "Generic Drug Labels: FDA Offers Draft Guidance on Updates After Reference Products are Withdrawn". Regulatory Focus. 11 August 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 August 2016.
Hamilton RJ (2010). Tarascon Pharmacopoeia 2010 Library Edition. Jones & Bartlett Learning. s. 170. ISBN 978-0-7637-7768-5. 13 January 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 September 2017.
"Anagraine - Drugs.com". Drugs.com. 29 August 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 May 2020.
Mikota SK, Plumb DC (June 2003). "Metoclopramide HCl". The Elephant Formulary. Elephant Care International. 29 December 2003 tarihinde kaynağından arşivlendi.

webmd.com

"FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs" (Basın açıklaması). U.S. Food and Drug Administration. 26 February 2009. 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009. "Lay Summary – WebMD". 18 January 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 June 2009.